Fresh tumor tissue should be used for any type of application such as for tissue transplantation and for nucleic acid isolation. For high quality RNA isolation, it is imperative that the tissue be flash frozen within 10-20 min after removal from the body to prevent degradation. For tissue transplantation, time is less critical, but the tissue should remain on ice and in medium until transplantation.
The materials that you will require are gloves, disposable bibs, sterile gauze, swabs, long, straight trimming blades, sterile scalpels, tissue culture dishes, sterile forceps, 50ml conical tubes, RNase/DNase-free cryovials, bleach, 70% ethanol, RNAlater (RNA Stabilization Reagent) and Dewar of liquid nitrogen.
You will have to coordinate tissue collection. The tissue collection staff checks the surgery schedule daily to identify the participants. The tissue collection staff also reviews and notes the patient history and the clinical diagnosis. A tissue collection coordinator alerts the surgeon, pathologist, investigator and tissue repository staff by e-mail 24 hr. prior to surgery.
Informed consent must be obtained from the patient prior to tissue collection. Prior to the surgical procedure, the repository technician communicates with the operating room staff that a specimen for research has been planned. The operating room staff notifies the tissue repository technician 10 min prior to when the tissue is removed from the patient. This will ensure that the repository technician can get to the operating room before the tissue is removed from the patient in order to minimize the amount of time prior to processing.
When the breast tissue is removed, the technician notes the time of the day, and places the tissue into a container on ice for immediate transport to the pathology laboratory. The specimen is potentially infectious and should be handled with blood-borne pathogen considerations. The pathologist verifies the patient identification and removes surplus tumor and adjacent uninvolved (normal) tissue for research purpose. The tissue type (cancerous or adjacent uninvolved), location within the breast from where the tissue was removed, and procurement time are noted on a specimen worksheet.
From each tissue about 30 mg pieces are placed into separate cryovials, and immediately flash frozen in liquid nitrogen. The frozen tissues are stored in vapor phase liquid nitrogen. You could also make additional 20 mg pieces from the tissue and place into separate cryovials containing 400 μl of RNAlater for RNA analysis. These tubes are stored at 4°C overnight. You could remove the RNAlater as per manufacturer’s directions and store the specimens at −80°C.
If you are left with extra tumor specimen, you could place the tissue into separate 50 mL conical tubes containing the growth media for immediate tissue implantation or disassociation to organoids if you are planning for such experiments.
It is important that you need to enter patient identification, specimen collection information, as well as storage information in a biospecimen tracking database.
We had experience of working with oncosurgeon. The most important thing we had to deal with was the timing. Sometimes, our fellow had to wait for a tissue more than 12hrs. We don't have -80 fridges at tissue collection site and don't have that much facilities. For tissue sample preservation, RNALater is a blessing for us. Part of the tumor tissues was kept for pathological tests and the rest was given to us for molecular analysis. Tissue sample was stored in RNALater containing tube immediately after collection, transported to lab in an icebox, and stored at -20C.
Collecting tumor samples from breast cancer patients requires careful adherence to protocols and ethical considerations. Here is a detailed protocol for tumor sample collection from breast cancer patients, along with necessary precautions to be taken:
Ethics and Informed Consent: Ensure compliance with ethical guidelines and obtain informed consent from patients for the collection and use of their tumor samples for research purposes. Maintain patient confidentiality and privacy throughout the process.
Standard Operating Procedures (SOPs): Develop and follow standard operating procedures specific to your research institution or laboratory. These SOPs should include guidelines for sample collection, processing, storage, and documentation.
Sterile Environment: Prepare a sterile environment, including a laminar flow hood, sterile instruments, gloves, masks, and appropriate personal protective equipment (PPE) to prevent contamination during the collection procedure.
Patient Preparation: Before the procedure, review patient medical records, including pathology reports and imaging studies, to identify the tumor location and characteristics. Coordinate with the clinical team to schedule the sample collection procedure.
Local Anesthesia: Administer local anesthesia to the patient at the site where the tumor is accessible for biopsy. This is typically done using lidocaine or a similar anesthetic agent to ensure patient comfort during the procedure.
Biopsy Technique: Perform a core needle biopsy or a surgical excision biopsy, depending on the specific research requirements and availability of resources. Ensure proper techniques are followed to obtain an adequate tumor sample while minimizing trauma to surrounding tissues.
Sample Handling: Handle the tumor sample with sterile instruments and transfer it to a sterile container or transport medium, such as RNAlater or formalin, as appropriate for the downstream analysis. Use separate containers for different analyses, such as histopathology or molecular profiling, if required.
Sample Documentation: Accurately label the sample container with patient identifiers, sample type, date, and any relevant clinical information. Maintain a comprehensive sample log or database to track sample information throughout the process.
Sample Processing: Process the tumor sample promptly according to the intended analysis. This may involve dividing the sample into multiple aliquots for different purposes, such as freezing sections for genomic analysis, fixation for histopathology, or isolation of specific cell populations.
Proper Storage: Store the processed samples in appropriate conditions, following established protocols for long-term storage. This may include freezing at ultra-low temperatures (-80°C or lower) or storing formalin-fixed samples in a controlled environment.
Data and Consent Management: Ensure proper data management, storage, and security of patient information in accordance with institutional guidelines and data protection regulations. Maintain a record of informed consent and any related documentation as required.
Quality Control: Implement quality control measures at each step to monitor the integrity and quality of the collected tumor samples. This includes maintaining a cold chain, validating sample handling procedures, and periodic auditing of sample storage conditions.
Remember to consult and collaborate with experienced researchers, pathologists, and institutional review boards to align your protocols with local regulations and best practices specific to your research setting.
It is crucial to prioritize patient safety, privacy, and ethical considerations throughout the entire process of tumor sample collection.